<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Vaccines</title>
    <link rel="stylesheet" href="style.css">
    <script src="https://kit.fontawesome.com/5fecc5a088.js" crossorigin="anonymous"></script>
</head>
<body>
    <nav id="navbar">
        <ul>
            <a href="/index.html"><img src="/bgnav.jpeg" id = "navimg"alt=""></a>
            <li><a href="/index.html">Home</a></li>
            <li><a href="/impacts.html">Impacts</a></li>
            <li><a href="/Safety.html">Protection</a>
                <div class="sub_menu">
                    <ul>
                        <li><a href="/Safety.html">Safety Measures</a></li>
                        <li><a href="/vaccine.html">Vaccines</a></li>
                        <li><a href ="/faqs.html">FAQs</a></li> 
                    </ul>
                    
                </div>
            </li>
            <li><a href="/more.html">More</a></li>
            <li><a href="/aboutpage.html">About</a></li>
            <!-- <li><a href="/"></a></li> -->
        </ul>
    </nav>
    <div class="container" style="background-image: url('/images/vacine.jpg'); background-size:cover; width:100%;height: 55rem; ">
        <h1>Vaccination in India
        </h1>
        <div class="intro">
            Two of the Covid–19 vaccines available in India are <b>Covaxin</b> by Bharat Biotech and <b>Covishield</b> by the Serum Institute of India, both been authorized for emergency use in India.
        </div>
        <ul class="accordian">
            <li>
                <input type="radio" name="accordion" id="first">
                <label for="first">Covaxin</label>
                <div class="content content_font">
                    Covaxin is Inactivated vaccine. Inactivated means that the virus used for the vaccine has no chance of infecting or replicating the receiver inside the body after the Jab has been given. Bharat biotech had given a commitment that it has a stockpile of 20 million doses of Covaxin and is also aiming for 700 million doses by the end of the year.
                    <ul class="innerlist">
                        <li><b>Dosage - </b>Bharat Biotech stated that the second shot would be given after 14 days to 28 days.</li>
                        <li><b>Efficacy - </b>81% according to interim 3rd phase trial results.</li>
                        <!-- <li><b>Acceptance - </b>Although the Government of India is reaching out to countries to accept Covaxin, only a limited number of countries have accepted the plea.</li> -->
                        <li><b>Side Effects - </b>Headeach, muscle pain, fever, swelling at the injection site. It can last upto 24 hours or more in case if it even lasts after 3 days consult a doctor.</li>
                        <li><b>Workability against the delta variant - </b>Efficacy rate of Covaxin against the delta variant is dropped to 61%.</li>
                        <li><b>Pricing -</b>Covaxin is available free of cost at government hospitals. However the price of each dose is ₹1410 at private hospitals.</li>
                    </ul>   
                </div>
            </li>
            <li>
                <input type="radio" name="accordion" id="second">
                <label for="second">Covishield</label>
                <div class="content content_font">
                    Oxford-AstraZeneca vaccine is produced locally by the Serum Institute of India, the world’s largest manufacturer of vaccines. It is said to produce more than 50 million doses a month. The vaccine, known as Covishield, is made from a weakened version of the common cold virus (known as adenovirus) from chimpanzees. It has been modified to look more like coronavirus, though it causes illness.
                    <ul class="innerlist">
                        <li><b>Dosage - </b>The gap between doses of Covishield is at least 84 to 104 days.</li>
                        <li><b>Efficacy - </b>90% according to interim 3rd phase trial results.</li>
                        <!-- <li><b>Acceptance - </b>Although the Government of India is reaching out to countries to accept Covaxin, only a limited number of countries have accepted the plea.</li> -->
                        <li><b>Side Effects - </b>Inflamation, fattigue, fever, burning eyes and swelling at the injection site. Any individual with severe allergies should check the constituents initially before taking the jab</li>
                        <li><b>Workability against the delta variant - </b>Efficacy rate of Covishield against the delta variant is dropped to 65%.</li>
                        <li><b>Pricing -</b>Covishield is available free of cost at government hospitals. However the price of each dose is ₹780 at private hospitals.</li>
                    </ul>   
                </div>
            </li>
        </ul>
        <button class="btn"><a href="https://selfregistration.cowin.gov.in/" target="_blank">Get yourself Registered for Vaccination</a></button>
    </div>
        <footer class="footer">
        <div class="col-1">
            <h3>USEFUL LINKS</h3>
            <a href="/index.html">Home</a>
            <a href="/impacts.html">Impacts</a>
            <a href="/faqs.html">FAQs</a>
            <a href="/aboutpage.html">About</a>
        </div>
        <div class="col-2">
            <h3>NEWSLETTER</h3>
            <form action="">
                <input type="email" placeholder="Enter your Email Address" required><br>
                <button>SUBSCRIBE NOW</button>
            </form>
            <div class="socialicons">
                <a href="https://www.linkedin.com/in/aditya-tiwari-39405b201/" target="_blank"><i class="fa-brands fa-linkedin-in"></i></a>
                <a href="https://instagram.com/_aditya_tiwari973?igshid=NmQ2ZmYxZjA=" target="_blank"><i class="fa-brands fa-instagram"></i></a>
                <a href="https://twitter.com/AdityaTiwari973" target="_blank"><i class="fa-brands fa-twitter"></i></a>
                <a href="https://github.com/Aditya973" target="_blank"><i class="fa-brands fa-github"></i></a>
            </div>
        </div>
        <div class="col-3">
            <h3>CONTACTS</h3>
            <div class="location">

            <i class="fa-sharp fa-solid fa-location-crosshairs"></i>Jabalpur Engineering College,<br>Jabalpur, Madhya Pradesh, India
            </div>
            <div class="phone">
                <i class="fas fa-mobile-alt"></i>+917440317440
                <br>
                <i class="far fa-at"></i><a href="mailto:tiwariaditya973@gmail.com">tiwariaditya973@gmail.com</a>    
                
            </div>
        </div>
    </footer>
</body>
</html>